Pemigatinib (FGFR2 Inhibitor)
Treatment used for 1 condition
Total Trials
30
Total Participants
1K
Avg Effectiveness
50%
Avg Safety Score
40%
Conditions Treated
Click on a condition to view detailed treatment information and clinical trial data.
Treatment used for 1 condition
Click on a condition to view detailed treatment information and clinical trial data.